💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Incyte Corporation (INCY)
« Back to company indexINCY Chatter Timeline
Stock Ticker for INCY
Most Active Tweeters for INCY
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @InsiderAlerts4U | 6 |
| @sleekoptions | 6 |
| @RVH_Investing | 4 |
| @optioncharts | 4 |
Recent Tweets for INCY
 |
@MarcJacksonLA $INCY JPM: Established relationships were key to pandemic drug launches, Incyte CEO says https://t.co/UGCUPRFFhu January 15th 2021, 9:01pm |
 |
@optioncharts $INCY Delta expiration 01/15/2021 #maxpain #options https://t.co/EA6Erh9FwJ https://t.co/0A9fD5Wxr3 January 15th 2021, 6:01pm |
 |
@sleekoptions Peak profit for the last 6 expired option alerts for $INCY 87.50% | 53.06% | 13.48% | -15.42% | 33.33% | -9.09% |… https://t.co/lvYecMSU5M January 15th 2021, 6:01pm |
|
@sleekoptions $INCY - Last six months, 13 option alerts peaked above 100% after they were triggered by the algo… https://t.co/IQIx7tO1qm January 15th 2021, 5:01pm |
|
@sleekoptions $INCY - View historical options performance for INCY https://t.co/fBAay8o89T https://t.co/7hqhmKYieQ January 15th 2021, 5:01pm |
 |
@RVH_Investing $CALA $INCY INCB001158 Biliary Tract Cancer Data in the AM. https://t.co/2mtRfTDglN January 15th 2021, 3:01am |
 |
@caseybloc $INCY pulled back to the 8ema https://t.co/T94ma71yyT January 15th 2021, 2:01am |
|
@RVH_Investing Everyone views the $CALA $INCY deal as DEAD so if INCY moves forward w/ this then the sentiment changes fast and al… https://t.co/mRhtxATJYh January 14th 2021, 3:01pm |
 |
@ResearchPool $INCY #Incyte Corp. INCY - Embedded Expectations Analysis - 2021 01 13: Incyte Corporation (INCY:USA) currently tra… https://t.co/Xua9UVXrGU January 14th 2021, 12:01am |
 |
@InsiderAlerts4U $INCY: New Insider Filing on INCYTE CORP's EVP & General Counsel MARIA E PASQUALE: https://t.co/J6tPsbUw2u January 13th 2021, 10:01pm |
 |
@john_bresnahan RT @BertrandBio: $MOR late-stage programs, more on Monjuvi expansion $INCY, partnered programs & 2021 newsflow #JPM21 Not much insights on… January 13th 2021, 9:01pm |
 |
@BertrandBio $MOR late-stage programs, more on Monjuvi expansion $INCY, partnered programs & 2021 newsflow #JPM21 Not much insi… https://t.co/0V0xkRj3on January 13th 2021, 9:01pm |
 |
@FlashAlert_me $INCY [15s. delayed] filed SEC form 4: EVP & General Counsel Pasquale Maria E: Converted securities 127 of Common… https://t.co/XrAe4i7V4V January 13th 2021, 9:01pm |
 |
@FutureFetish007 @3PeaksTrading AMD is faaar ahead of $INCy but longer term I think America NEEDS domestic chip production. Who will that be if not Intel. January 13th 2021, 6:01pm |
 |
@swingtrader19 $INCY A pullback to buy the dip imo.. Bull flag forming and next break out to $100+ should be sooner than later, we will see! January 13th 2021, 5:01pm |
|
@MarcJacksonLA $MOR $INCY Incyte and MorphoSys Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab | B… https://t.co/TIjarc1wU3 January 13th 2021, 3:01pm |
 |
@Gambiste1 RT @kevinjaybe: $INCY and MorphoSys Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab https://t.co/ECnlrfS1PO January 13th 2021, 10:01am |
 |
@1stOncology #MorphoSys and #Incyte Announce Acceptance by Health Canada of the New Drug Submission for #Tafasitamab $MOR $INCY https://t.co/NrHt234yrr January 13th 2021, 9:01am |
|
@optioncharts $INCY high OI range is 80.00 to 115.00 for option expiration 01/15/2021 PutCallRatio=0.56 #maxpain #options… https://t.co/dGNZ57k4gX January 13th 2021, 4:01am |
 |
@theflynews MorphoSys, Incyte say Health Canada accepts tafasitamab new drug submission $MOR $INCY https://t.co/vBWmUGHEKa January 12th 2021, 10:01pm |
 |
@sbwcws MorphoSys, Incyte say Health Canada accepts tafasitamab new drug submission $MOR $INCY January 12th 2021, 9:01pm |
 |
@Beeken_health $INCY $MOR - MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab… https://t.co/TSVw8QdxRV January 12th 2021, 9:01pm |
 |
@Zap_Trades MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab $INCY January 12th 2021, 9:01pm |
 |
@MarketCurrents $INCY $MOR - Incyte/MorphoSys' tafasitamab Canada application accepted for review https://t.co/jh7HuH99qk January 12th 2021, 9:01pm |
 |
@kevinjaybe $INCY and MorphoSys Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab https://t.co/ECnlrfS1PO January 12th 2021, 9:01pm |
 |
@InaraBright $INCY - INCYTE AND MORPHOSYS ANNOUNCE ACCEPTANCE BY HEALTH CANADA OF THE NEW DRUG SUBMISSION FOR TAFASITAMAB January 12th 2021, 9:01pm |
|
@kevinjaybe $INCY Leerink maintains Market Perform, raises PT from 85 to 89 January 12th 2021, 6:01pm |
 |
@Tickeron $INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on January 7, 2021. View odds for this and other… https://t.co/cx8Uy3fBcO January 12th 2021, 4:01am |
|
@RVH_Investing RT @biosleuth: $CALA $INCY INCB001158 update in BTC at ASCO GI Friday Premkt https://t.co/jRmzFo0kJ0 January 12th 2021, 3:01am |
 |
@DereckCoatney $INCY is beginning its breakout: https://t.co/Qxo33GC5wh https://t.co/aEIIgYmxAP January 12th 2021, 3:01am |
|
@caseybloc $INCY Getting some action https://t.co/V4leQhJwHd January 12th 2021, 3:01am |
 |
@biosleuth $CALA $INCY INCB001158 update in BTC at ASCO GI Friday Premkt https://t.co/jRmzFo0kJ0 January 11th 2021, 11:01pm |
 |
@PMDiChristina Still liking this $INCY https://t.co/TtjsIgoEWZ January 11th 2021, 10:01pm |
 |
@ClockworkAlerts #NASDAQ | #Incyte Corp., $INCY, 3 out of 3, (+$3,610) today with #daVinci III, our 100% #algorithmic #daytrading mo… https://t.co/YcGuwX69p5 January 11th 2021, 9:01pm |
 |
@Jailerma RT @JesseL1verm0re: I am a $cala buyer. Too much of a pipeline for this valuation: 1158 data from $incy, 280 data probably this Q, KEAPSAKE… January 11th 2021, 1:01pm |
 |
@MarketChmln $INCY option volume was 4X normal on Friday with 2,904 contracts. Call volume was 91% and put volume was 9%. https://t.co/ZT4gLLoGzU January 11th 2021, 3:01am |
|
@Gambiste1 RT @RipShowStocks: $INCY Breakout and back over the its 200DMA. https://t.co/ktWEA1ZgHT January 10th 2021, 11:01pm |
 |
@RipShowStocks $INCY Breakout and back over the its 200DMA. https://t.co/ktWEA1ZgHT January 10th 2021, 11:01pm |
 |
@cfromhertz $INCY Incyte Corporation retakes 200d MA and breaks out of value https://t.co/duq0liKQzW January 10th 2021, 8:01pm |
 |
@tradersreport RT @Tickeron: $INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on January 7, 2021. View odds for this and other indicator… January 10th 2021, 4:01am |
|
@Tickeron $INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on January 7, 2021. View odds for this and other… https://t.co/0pFqp7i0zk January 10th 2021, 4:01am |
|
@optioncharts $INCY high OI range is 80.00 to 115.00 for option expiration 01/15/2021 PutCallRatio=0.67 #maxpain #options… https://t.co/Hb0FQypDy9 January 9th 2021, 7:01pm |
 |
@spontonic @sentivcapital @abbynac $INCY January 8th 2021, 5:01pm |
|
@Tickeron $INCY's price moved below its 50-day Moving Average on January 6, 2021. View odds for this and other indicators:… https://t.co/niKdOpo7Ss January 7th 2021, 2:01pm |
 |
@pivotanalytics Trade Idea In $INCY https://t.co/QrsuvFJSXS https://t.co/iB9NPwsPlN January 7th 2021, 11:01am |
|
@RVH_Investing - $CALA $INCY 1158 chemo data Monday, Jan. 11th - CB-280 update probably sometime around Feb-May 21' - KEAPSAKE dat… https://t.co/0yYR9wUgx0 January 7th 2021, 8:01am |
 |
@mediasentiment $INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 486 January 7th 2021, 8:01am |
|
@kevinjaybe $INCY Truist Sec initiates with Buy, PT 120 January 7th 2021, 6:01am |
 |
@BioStocks $INCY initiated with a Buy at Truist. PT $120 January 7th 2021, 6:01am |
 |
@sbwcws Incyte initiated with a Buy at Truist $INCY January 7th 2021, 6:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
